Access to anti-retroviral drugs, female in Indonesia
Indonesia: Access to anti-retroviral drugs, female was 36.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Indonesia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Indonesia is 36.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 24.1% on the previous year and up 227.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Indonesia peaked at 36.0% in 2024 and was at its lowest, 0.0%, in 2000.
Indonesia ranks 130th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Indonesia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 3.0% | +50.0% |
| 2008 | 3.0% | +0.0% |
| 2009 | 5.0% | +66.7% |
| 2010 | 5.0% | +0.0% |
| 2011 | 6.0% | +20.0% |
| 2012 | 7.0% | +16.7% |
| 2013 | 8.0% | +14.3% |
| 2014 | 11.0% | +37.5% |
| 2015 | 14.0% | +27.3% |
| 2016 | 16.0% | +14.3% |
| 2017 | 18.0% | +12.5% |
| 2018 | 21.0% | +16.7% |
| 2019 | 23.0% | +9.5% |
| 2020 | 26.0% | +13.0% |
| 2021 | 26.0% | +0.0% |
| 2022 | 27.0% | +3.8% |
| 2023 | 29.0% | +7.4% |
| 2024 | 36.0% | +24.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.3% | 0.0% | 5.0% | 10 |
| 2010s | 12.9% | 5.0% | 23.0% | 10 |
| 2020s | 28.8% | 26.0% | 36.0% | 5 |
Countries ranked near Indonesia
- 127 Syrian Arab Republic 41.0% compare
- 128 Madagascar 39.0% compare
- 129 Afghanistan 38.0% compare
- 130 Mongolia 36.0% compare
- 132 Yemen 34.0% compare
- 133 Bangladesh 33.0% compare
- 133 Congo 33.0% compare
- 133 Tunisia 33.0% compare
More gender data for Indonesia
- Child population (UN estimates and projections) 66,364 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7373 % change on previous year (2030)
- Population 229,513 (2030)
- Working-age population (UN estimates and projections) 229,513 (2030)
- Population (UN estimates and projections), annual growth rate 1.05 % change on previous year (2030)
- Age population, age 00, female, interpolated 2.13 million (2025)
- Age population, age 00, male, interpolated 2.26 million (2025)
- Age population, age 01, female, interpolated 2.14 million (2025)
- Age population, age 01, male, interpolated 2.26 million (2025)
- Age population, age 02, female, interpolated 2.15 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Indonesia?
- Access to anti-retroviral drugs, female in Indonesia was 36.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Indonesia?
- The highest recorded value was 36.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Indonesia?
- The lowest recorded value was 0.0% in 2000.
- How does Indonesia rank for access to anti-retroviral drugs, female?
- Indonesia ranks 130th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Indonesia?
- Over the last ten years it is up 227.3%. The long-run trend across the full record is volatile.
- Where does this Indonesia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.